Contribute Try STAT+ Today

Moderna Therapeutics, a multibillion-dollar biotech startup, is raising $500 million in a round that values the company at $7.5 billion, according to the data provider Pitchbook.

The financing, first reported by Bloomberg, comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform the body’s cells into drug factories. The company has raised more than $1.5 billion since its inception in 2010, repeatedly putting off a public offering as it worked through setbacks that delayed its most ambitious science.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I would like to know when your company will go public.
    Please add me to your mailing list.

  • You continue to be the Sean Hannity of biotech quasi journalism. Spin for the win dude. Maybe you’re right, this whole thing at Moderna is a multibillion dollar scam.. Unfortunately, they are not Theranos, this is not and never was investigative journalism and there is no Pulitzer on the horizon.

Comments are closed.